Quince Therapeutics Quote - QNCX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.61

Bid

1.49

Ask

2.08

Volume

57,814

1.59 Day's Range 1.69

0.5116 52 Week Range 2.45

Market Cap

70.843M

Previous Close

1.60

Open

1.60

Last Trade

1.5999

Last Trade Time

Financial Volume

US$ 94,229

VWAP

1.6299

Average Volume (3m)

248,754

Shares Outstanding

44,001,643

Dividend Yield

PE Ratio

-2.73

Earnings Per Share (EPS)

-0.71

Revenue

Net Profit

-31.39M

Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug ... Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. The company's Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patient's own red blood cells. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

quincetx.com

Headquarters

Wilmington, Delaware, USA

Founded

Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was US$1.60. Over the last year, Quince Therapeutics shares have traded in a share price range of US$ 0.5116 to US$ 2.45.

Quince Therapeutics currently has 44,001,643 shares outstanding. The market capitalization of Quince Therapeutics is US$70.40 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -2.73.

Quince Therapeutics to Host Investor Webinar on February 7, 2025 Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that...

Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, announced the online...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	1.25786163522	1.59	1.78	1.545	78456	1.64892995	CS
4	-0.31	-16.1458333333	1.92	2.0397	1.4001	138034	1.72235376	CS
12	0.08	5.22875816993	1.53	2.45	1.4001	248754	1.86391045	CS
26	0.86	114.666666667	0.75	2.45	0.5116	390853	1.31701232	CS
52	0.41	34.1666666667	1.2	2.45	0.5116	238420	1.2545842	CS
156	-4.26	-72.5724020443	5.87	7.28	0.5116	437569	1.81491777	CS
260	-50.03	-96.8822618125	51.64	121.98	0.5116	459536	13.06082237	CS

QNCX - Frequently Asked Questions (FAQ)

What is the current Quince Therapeutics share price?

The current share price of Quince Therapeutics is US$ 1.61

How many Quince Therapeutics shares are in issue?

Quince Therapeutics has 44,001,643 shares in issue

What is the market cap of Quince Therapeutics?

The market capitalisation of Quince Therapeutics is USD 70.4M

What is the 1 year trading range for Quince Therapeutics share price?

Quince Therapeutics has traded in the range of US$ 0.5116 to US$ 2.45 during the past year

What is the PE ratio of Quince Therapeutics?

The price to earnings ratio of Quince Therapeutics is -2.73

What is the reporting currency for Quince Therapeutics?

Quince Therapeutics reports financial results in USD

What is the latest annual profit for Quince Therapeutics?

The latest annual profit of Quince Therapeutics is USD -31.39M

What is the registered address of Quince Therapeutics?

The registered address for Quince Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Quince Therapeutics website address?

The website address for Quince Therapeutics is quincetx.com

Which industry sector does Quince Therapeutics operate in?

Quince Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
REBNReborn Coffee Inc	US$ 3.31 (63.05%)	55.54M
FCUVFocus Universal Inc	US$ 5.87 (56.62%)	1.73M
SOPASociety Pass Inc	US$ 1.54 (56.50%)	13.82M
CYCNCyclerion Therapeutics Inc	US$ 3.92 (54.33%)	82.39M
ENVBEnveric Biosciences Inc	US$ 2.0899 (-46.41%)	1.57M
NIVFNewGenIvf Group Ltd	US$ 0.1489 (-42.51%)	14.8M
GLSTGlobal Star Acquisition Inc	US$ 8.83 (-39.10%)	23.89k
PRPHProPhase Labs Inc	US$ 0.2633 (-38.02%)	872.46k
SPGCSacks Parente Golf Inc	US$ 0.5601 (-37.86%)	7.27M
TCTMTCTM Kids IT Education Inc	US$ 0.764 (321.87%)	729.72M
NVDANVIDIA Corporation	US$ 120.07 (-3.67%)	388.54M
RIMEAlgorhythm Holdings Inc	US$ 0.02565 (5.12%)	338.75M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0355 (-11.25%)	236.29M
CLEUChina Liberal Education Holdings Ltd	US$ 0.1938 (30.77%)	234.8M